The strongest effect was observed for CAF#3-CM, the CAF culture that expressed the highest level of NRG1.Treament with lumretuzumab of cancer cells cultured in control media, did not alter their migration abilities, confirming the absence of an autocrine HER3 activation (Fig. S3B). This evidence concerns the gene NRG1 and cancer.